Telix Pharmaceuticals Correlations

TLPPF Stock  USD 16.00  0.82  5.40%   
The current 90-days correlation between Telix Pharmaceuticals and Sino Biopharmaceutical Ltd is -0.12 (i.e., Good diversification). The correlation of Telix Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Telix Pharmaceuticals Correlation With Market

Good diversification

The correlation between Telix Pharmaceuticals Limited and DJI is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals Limited and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Telix Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Telix Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Telix Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Telix Pharmaceuticals Limited to buy it.

Moving together with Telix Pink Sheet

  0.77SLF Sun Life FinancialPairCorr
  0.63AVTE Aerovate TherapeuticsPairCorr
  0.67BAC Bank of America Fiscal Year End 10th of January 2025 PairCorr
  0.66GOOG Alphabet Class C Aggressive PushPairCorr
  0.81PYPL PayPal Holdings Aggressive PushPairCorr
  0.67JPM JPMorgan Chase Fiscal Year End 10th of January 2025 PairCorr
  0.69CVX Chevron Corp Fiscal Year End 7th of February 2025 PairCorr
  0.65T ATT Inc Fiscal Year End 22nd of January 2025 PairCorr
  0.74AXP American Express Fiscal Year End 24th of January 2025 PairCorr
  0.76HD Home DepotPairCorr
  0.69DIS Walt DisneyPairCorr
  0.76CSCO Cisco SystemsPairCorr
  0.63CAT Caterpillar Sell-off TrendPairCorr
  0.73WMT WalmartPairCorr

Moving against Telix Pink Sheet

  0.71REGN Regeneron PharmaceuticalsPairCorr
  0.7MCAE Mountain Crest AcquiPairCorr
  0.68NVO Novo Nordisk ASPairCorr
  0.66NONOF Novo Nordisk ASPairCorr
  0.63CSLLY CSLPairCorr
  0.56CMXHF CSL LimitedPairCorr
  0.51NIHK Video River NetworksPairCorr
  0.42QSAM Qsam BiosciencesPairCorr
  0.37SGEN Seagen IncPairCorr
  0.32GLUC Glucose HealthPairCorr
  0.69PFE Pfizer Inc Fiscal Year End 4th of February 2025 PairCorr
  0.63KO Coca Cola Fiscal Year End 11th of February 2025 PairCorr
  0.63MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
ENLVALRN
LVCLFENLV
MRZMDTCFF
ENLVDTCFF
MRZMENLV
MRZMALRN
  
High negative correlations   
ENLVSBHMY
LVCLFSBHMY
ALRNSBHMY
LVCLFALRN
MRZMSBHMY
MRZMLVCLF

Risk-Adjusted Indicators

There is a big difference between Telix Pink Sheet performing well and Telix Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Telix Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
SBHMY  0.62  0.19  0.00  0.99  0.00 
 0.00 
 25.86 
DTCFF  0.75  0.09  0.00 (0.22) 0.00 
 0.00 
 25.87 
ALRN  4.44 (0.23) 0.00 (0.34) 0.00 
 9.81 
 41.47 
ENLV  3.42 (0.36) 0.00 (0.53) 0.00 
 9.03 
 26.52 
LVCLF  1.99 (0.47) 0.00 (0.38) 0.00 
 0.00 
 66.02 
MCET  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
HESG  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
MYMX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
MRZM  9.04  2.04  0.05 (0.42) 10.21 
 33.33 
 128.57 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Telix Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Analyzer Now

   

Portfolio Analyzer

Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
All  Next Launch Module

Telix Pharmaceuticals Corporate Management

Jyoti BappScChief APACProfile
Meredith CroweInterim CultureProfile
BSc BScChief ScientistProfile
Christian DavisEMEA MarketingProfile
Andreas MDChief DirectorProfile
Amanda GriffinCommunications MangProfile
BEng DPhilGroup CoFounderProfile